Role of lysosomes and cathepsin inhibitor in plasma during pneumococcal infection.
D000380:Agranulocytosis / Q000201:enzymology; D000818:Animals; D000963:Antimetabolites / Q000097:blood* / Q000302:isolation & purification; D002302:Cardiac Output; D002403:Cathepsins / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D008099:Liver / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology*; D008297:Male; D008466:Mechlorethamine / Q000494:pharmacology; D009132:Muscles / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D010196:Pancreatic Elastase / Q000032:analysis; D011008:Pneumococcal Infections / Q000201:enzymology / Q000209:etiology*; D011773:Pyruvates / Q000097:blood; D011817:Rabbits; D018805:Sepsis / Q000401:mortality; D012790:Shwartzman Phenomenon
D000963:Antimetabolites; D011773:Pyruvates; D008466:Mechlorethamine; D002403:Cathepsins; D010196:Pancreatic Elastase